JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95
JP Morgan analyst Benjamin Rossi maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target from $90 to $95.
A big investment bank thinks US Physical Therapy is a good company and raised how much they think its stock is worth by five dollars. When experts feel more confident about a company, it can mean the business is doing well or they see good things coming.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.